The University of Queensland has been selected as one of the first launch institutions in the world to partner with biotechnology company Moderna to research and develop vaccines to tackle the world’s greatest global public health threats.
10 March 2022
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
20 October 2021
Issues critical to communities across the world will be discussed at an international symposium in Brisbane from September 22 to 25.
20 September 2016
